Shelter Pharma Ltd Financials
Company Logo

Shelter Pharma Ltd Financial Statement

Shelter Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Shelter Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual50.66
Operating Expenses Annual40.59
Operating Profit Annual10.07
Interest Annual0.13
Depreciation0.27
Net Profit Annual7.24
Tax Annual2.44

Shelter Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning5.04
Cash Flow from Operations5.48
Cash Flow from Investing-7.13
Cash Flow from Financing0.03
Cash Flow at the End3.42

Shelter Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)19.90
PBIT Margin (%)19.36
PBT Margin (%)-129.59
Net PROFIT Margin (%)14.29
Return On Networth / Equity (%)18.89
Return On Networth /Employed (%)25.03
Return On Assets (%)18.01
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)1.26

Shelter Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual5.96
Total Current Assets Annual33.28
Non Current Assets Annual15.06
Total Shareholders Funds Annual42.72
Total Assets Annual48.34

Shelter Pharma Ltd Earning Calls

No Data Availabe

FAQS on Shelter Pharma Ltd Financials

As of Sep 18, 2025, Shelter Pharma Ltd has a market capitalization of 41.85 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Shelter Pharma Ltd is with a debt-to-equity ratio of 0.02.

In FY 2024 , Shelter Pharma Ltd recorded a total revenue of approximately 50.66 Cr marking a significant milestone in the company's financial performance.

Shelter Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..

Shelter Pharma Ltd's current PE ratio is 5.78.

Shelter Pharma Ltd's ROCE averaged 31.2% from the FY ending March 2023 to 2025, with a median of 22.9%. It peaked at 48.3% in March 2023, reflecting strong capital efficiency over the period..

Shelter Pharma Ltd's latest EBIT is Rs. 9.81 Cr, surpassing the average EBIT of Rs. 8.38 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions